Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,401 to 2,420 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| LGALS3BP galectin 3 binding protein | 3959 HGNC:6564 | 1 | 144 | 0 | 0 | 1,433 | 2,653 |
| MIR99A microRNA 99a | 407055 HGNC:31650 | 0 | 0 | 0 | 0 | 948 | 2,653 |
| IDE insulin degrading enzyme | 3416 HGNC:5381 | 1 | 57 | 0 | 0 | 1,941 | 2,652 |
| UROD uroporphyrinogen decarboxylase | 7389 HGNC:12591 | 1 | 21 | 0 | 0 | 496 | 2,652 |
| RARG retinoic acid receptor gamma | 5916 HGNC:9866 | 1 | 46 | 11 | 502 | 1,608 | 2,651 |
| UBE2C ubiquitin conjugating enzyme E2 C | 11065 HGNC:15937 | 1 | 44 | 0 | 0 | 1,381 | 2,651 |
| DLAT dihydrolipoamide S-acetyltransferase | 1737 HGNC:2896 | 1 | 46 | 0 | 0 | 1,136 | 2,650 |
| SETBP1 SET binding protein 1 | 26040 HGNC:15573 | 1 | 25 | 0 | 0 | 1,706 | 2,649 |
| TNFRSF13B TNF receptor superfamily member 13B | 23495 HGNC:18153 | 1 | 220 | 0 | 0 | 1,652 | 2,649 |
| ACR acrosin | 49 HGNC:126 | 1 | 22 | 0 | 0 | 1,192 | 2,647 |
| BCL10 BCL10 immune signaling adaptor | 8915 HGNC:989 | 1 | 45 | 0 | 0 | 1,639 | 2,643 |
| GDF10 growth differentiation factor 10 | 2662 HGNC:4215 | 1 | 61 | 0 | 0 | 2,004 | 2,641 |
| BLMH bleomycin hydrolase | 642 HGNC:1059 | 1 | 21 | 0 | 0 | 1,117 | 2,639 |
| BAG3 BAG cochaperone 3 | 9531 HGNC:939 | 1 | 90 | 0 | 0 | 1,566 | 2,636 |
| CRY1 cryptochrome circadian regulator 1 | 1407 HGNC:2384 | 1 | 22 | 0 | 0 | 1,657 | 2,635 |
| PTAFR platelet activating factor receptor | 5724 HGNC:9582 | 1 | 45 | 3 | 7 | 1,025 | 2,635 |
| MAPKAP1 MAPK associated protein 1 | 79109 HGNC:18752 | 1 | 16 | 0 | 0 | 1,838 | 2,634 |
| TNFRSF13C TNF receptor superfamily member 13C | 115650 HGNC:17755 | 1 | 211 | 1 | 31 | 1,520 | 2,634 |
| SMG1 SMG1 nonsense mediated mRNA decay associated PI3K related kinase | 23049 HGNC:30045 | 1 | 23 | 0 | 0 | 1,515 | 2,633 |
| TGFBR3 transforming growth factor beta receptor 3 | 7049 HGNC:11774 | 1 | 115 | 0 | 0 | 1,965 | 2,633 |
Code
curl "https://conductscience.org/api/genes/v1?page=121"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=121
{
"data": {
"total": 193990,
"results": [
{
"id": "3959",
"title": "LGALS3BP: galectin 3 binding protein",
"summary": "NCBI Gene 3959. 1 protein, 144 patents, 0 drugs, 0 trials, 1,433 NIH grants and 2,653 papers.",
"record": "/library/genes/3959",
"gene_id": 3959,
"symbol": "LGALS3BP",
"name": "galectin 3 binding protein",
"hgnc_id": "HGNC:6564",
"counts": {
"proteins": 1,
"patents": 144,
"drugs": 0,
"trials": 0,
"grants": 1433,
"papers": 2653
}
},
{
"id": "407055",
"title": "MIR99A: microRNA 99a",
"summary": "NCBI Gene 407055. 0 proteins, 0 patents, 0 drugs, 0 trials, 948 NIH grants and 2,653 papers.",
"record": "/library/genes/407055",
"gene_id": 407055,
"symbol": "MIR99A",
"name": "microRNA 99a",
"hgnc_id": "HGNC:31650",
"counts": {
"proteins": 0,
"patents": 0,
"drugs": 0,
"trials": 0,
"grants": 948,
"papers": 2653
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=122",
"request_id": "6tuVYnZ-CvwR4nHV"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant